bearish

Aier Eye Hospital Group

Aier Eye Hospital Group (300015.CH) 2021/2022Q1 Results - Overvaluation and a Risky Outlook

Even Aier's private placement was approved, it doesn't signal a complete policy shift for private medical institutions. Aier is overvalued, which has not priced in all the potential concerns and risks

Equity Bottom-Up
271 Views, 18 May 2022 08:44
SUMMARY(Sign Up to Access)
or
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
WHAT’S TRENDING
Insights
  • Trending
  • Latest
Logo
Top Quartile
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
ChinaHealth CareEquity Bottom-UpThematic (Sector/Industry)

Over 13 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in ... 

Price Chart(Sign Up to Access)
analytics-chart
x